Published in Neurosci Lett on September 23, 1988
Corticosteroids regulate 5-HT(1A) but not 5-HT(1B) receptor mRNA in rat hippocampus. Brain Res Mol Brain Res (2000) 0.79
Steroid effects on brain functions: an example of the action of glucocorticoids on central dopaminergic and neurotensinergic systems. J Psychiatry Neurosci (1995) 0.75
Quantitative RT-PCR: limits and accuracy. Biotechniques (1996) 6.88
Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor. J Steroid Biochem Mol Biol (1994) 1.84
Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem (2002) 1.73
RU 38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation. J Steroid Biochem (1984) 1.46
[The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy]. C R Seances Acad Sci III (1982) 1.26
Autoradiographic localization of glucocorticosteroid and progesterone binding sites in the human post-mortem brain. J Steroid Biochem (1986) 1.08
Hormonal regulation of apoptosis in breast cells and tissues. Steroids (2000) 1.07
RU 38486: a potent antiglucocorticoid in vitro and in vivo. J Steroid Biochem (1985) 1.07
The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J Neurochem (2007) 1.04
Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience (2009) 1.04
Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J Neurochem (2006) 1.03
Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J Comp Neurol (1996) 1.02
Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. Trends Pharmacol Sci (1997) 1.01
17 alpha-alkynyl-11 beta, 17-dihydroxyandrostane derivatives : a new class of potent glucocorticoids. Steroids (1981) 1.01
In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. J Pharmacol Exp Ther (1994) 1.00
Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin. Neuroscience (1987) 0.96
Progesterone and RU486: opposing effects on human sperm. Proc Natl Acad Sci U S A (1994) 0.94
Resistance to induced apoptosis in the human neuroblastoma cell line SK-N-SH in relation to neuronal differentiation. Role of Bcl-2 protein family. Eur J Biochem (2001) 0.94
Increased plasma neurotensin concentrations in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2001) 0.93
RU 486. Sci Am (1990) 0.93
The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes. Br J Pharmacol (1994) 0.92
Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution. Eur J Pharmacol (1987) 0.92
Progesterone binding in the immature mouse and rat uterus. Steroids (1973) 0.91
Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells. Life Sci (1998) 0.90
Comparative study of estrogen action. Mol Pharmacol (1973) 0.90
Automated keratoconus detection using the EyeSys videokeratoscope. J Cataract Refract Surg (2000) 0.90
Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients. Am J Psychiatry (1980) 0.89
Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders. J Steroid Biochem Mol Biol (1998) 0.89
Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra. J Neurosci (1998) 0.88
Ornithine decarboxylase induction by glucocorticoids in brain and liver of adrenalectomized rats. J Neurochem (1982) 0.88
Contragestion by antiprogestin RU 486: a review. Arch Gynecol Obstet (1987) 0.87
Neurotensin agonist induces differential regulation of neurotensin receptor mRNA. Identification of distinct transcriptional and post-transcriptional mechanisms. J Biol Chem (1997) 0.87
Evidence for a specific mineralocorticoid receptor in rat pituitary and brain. J Steroid Biochem (1980) 0.87
Steroid hormone receptors and pharmacology. J Steroid Biochem (1980) 0.87
Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity. Neuroreport (2001) 0.86
A new neuroregulator: the vasoactive intestinal peptide or VIP. Mol Cell Endocrinol (1982) 0.85
Design of ligands for the glucocorticoid and progestin receptors. Biochem Soc Trans (1991) 0.85
Mechanism of action of an antiprogesterone, RU486, in the rabbit endometrium. Effects of RU486 on the progesterone receptor and on the expression of the uteroglobin gene. Eur J Biochem (1985) 0.85
[3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum. Neurosci Lett (1990) 0.85
Steroid hormone receptors in human meningiomas, gliomas and brain metastases. J Neurooncol (1983) 0.84
RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism. J Steroid Biochem Mol Biol (1994) 0.84
Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization. Brain Res Dev Brain Res (1999) 0.84
Chronic cocaine increases neurotensin gene expression in the shell of the nucleus accumbens and in discrete regions of the striatum. Brain Res Mol Brain Res (1997) 0.84
The pure antiandrogen RU 23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review. Prostate (1984) 0.84
Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice. Neuropsychopharmacology (2001) 0.83
Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells. J Neuroimmunol (2000) 0.83
Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems. Brain Res (1996) 0.83
Estrogen-sensitive progestin-binding sites in the female rat brain and pituitary. Brain Res (1979) 0.82
The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells. J Neuroendocrinol (2007) 0.82
Immunologic differentiation of two high-affinity neurotensin receptor isoforms in the developing rat brain. J Comp Neurol (2000) 0.82
A progesterone metabolite enhances the activity of the GABAA receptor complex at the pituitary level. Eur J Pharmacol (1989) 0.82
Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities. J Mol Endocrinol (1997) 0.81
[Steroid receptors in the central nervous system. Implications in neurology]. Rev Neurol (Paris) (1984) 0.81
Glucocorticoid binding sites in human temporal cortex. Brain Res (1988) 0.81
Properties of the cytoplasmic progestin-binding protein in the rabbit uterus. Endocrinology (1977) 0.81
Regulation of human corneal epithelial cell proliferation and apoptosis by dexamethasone. Invest Ophthalmol Vis Sci (2000) 0.81
Stromal-cell-derived factor 1alpha /CXCL12 modulates high-threshold calcium currents in rat substantia nigra. Eur J Neurosci (2008) 0.81
11 beta-Amidoalkoxyphenyl estradiols, a new series of pure antiestrogens. J Steroid Biochem Mol Biol (1994) 0.81
Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity. Mol Endocrinol (2000) 0.81
11 beta-amidoalkyl estradiols, a new series of pure antiestrogens. J Steroid Biochem Mol Biol (1992) 0.81
In vitro effects of dexamethasone on human corneal keratocytes. Invest Ophthalmol Vis Sci (1999) 0.81
[Preparation of iodinated standards for quantitative radioautography in vitro using a tritium-sensitive film]. C R Acad Sci III (1985) 0.80
Specific progesterone receptors in dimethylbenzanthracene (DMBA)-induced mammary tumors. Steroids (1976) 0.80
Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists. Neuroendocrinology (1994) 0.80
Different subcellular localization of neurotensin-receptor and neurotensin-acceptor sites in the rat brain dopaminergic system. J Neurochem (1988) 0.80
Coexpression of alpha and gamma enolase genes in neurons of adult rat brain. J Neurosci Res (1994) 0.80
Screening for anti-hormones by receptor studies. J Steroid Biochem (1975) 0.80
Antiglucocorticoid properties of RU 38486 in a differentiated hepatoma cell line. Biochem Pharmacol (1983) 0.80
Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems. J Neurochem (1998) 0.80
Characterization and visualization of neurotensin binding to receptor sites in human brain. Biochem Biophys Res Commun (1984) 0.80
Effects of dexamethasone and forskolin on neurotensin production in rat hypothalamic cultures. Endocrinology (1995) 0.79
Synthesis of a fluorescent steroid derivative with high affinities for the glucocorticoid and progesterone receptors. Steroids (1994) 0.79
The effect of the antimineralocorticoid RU 28318 on aldosterone biosynthesis in vitro. J Steroid Biochem (1984) 0.79
Growth hormone-releasing hormone-synthesizing neurons are a subpopulation of somatostatin receptor-labelled cells in the rat arcuate nucleus: a combined in situ hybridization and receptor light-microscopic radioautographic study. Neuroendocrinology (1992) 0.79
Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture. Proc Natl Acad Sci U S A (1981) 0.79
RU 58,668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice. J Steroid Biochem Mol Biol (1994) 0.79
Regio and stereospecific synthesis of 11 beta-substituted 19-norsteroids. Influence of 11 beta-substitution on progesterone receptor affinity - (1). Steroids (1981) 0.79
Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors. J Neurosci (1992) 0.79
Rapid inhibition by somatostatin of vasoactive intestinal peptide-induced prolactin secretion by rat pituitary cells. Relationship to cyclic AMP accumulation. FEBS Lett (1982) 0.79
Activation of receptor gene transcription is required to maintain cell sensitization after agonist exposure. Study on neurotensin receptor. J Biol Chem (1998) 0.79
RU 58668: further in vitro and in vivo pharmacological data related to its antitumoral activity. J Steroid Biochem Mol Biol (1996) 0.79
Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine. Neuropsychopharmacology (1998) 0.79
Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus. J Neuroendocrinol (1997) 0.79
History and perspectives of antiprogestins from the chemist's point of view. Hum Reprod (1994) 0.79
Characterization and autoradiographic distribution of neurotensin binding sites in the human brain. Brain Res (1985) 0.79
Progestin binding sites in the rat hypothalamus pituitary and uterus. Steroids (1977) 0.79
High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR. J Mol Neurosci (1997) 0.79
Control of birth in rats by RU 486, an antiprogesterone compound. J Reprod Fertil (1987) 0.79
Electron microscopic localization of neurotensin binding sites in the midbrain tegmentum of the rat. I. Ventral tegmental area and the interfascicular nucleus. J Neurosci (1989) 0.79
Structure-activity relationships of a new family of steroidal aromatase inhibitors. 1. Synthesis and evaluation of a series of analogs related to 19-[(methylthio)methyl]androstenedione (RU54115). J Med Chem (1996) 0.78
Marked variations of the relative distributions of neurotensin and neuromedin N in micropunched rat brain areas suggest differential processing of their common precursor. Neurosci Lett (1991) 0.78
[Neurotensin/dopamine interactions]. Encephale (1989) 0.78
Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin. Life Sci (1996) 0.78